Cosmo Pharmaceuticals NV
LSE:0RGI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cosmo Pharmaceuticals NV
LSE:0RGI
|
IE |
|
C
|
Chocoladefabriken Lindt & Spruengli AG
DUS:LSPP
|
CH |
|
E
|
Everyday People Financial Corp
XTSX:EPF
|
CA |
|
F
|
Faisal Spinning Mills Ltd
KAR:FASM
|
PK |
|
A
|
Amotiv Ltd
OTC:GUDDY
|
AU |
|
Global Battery Metals Ltd
XTSX:GBML
|
CA |
|
K
|
Kosmos Energy Ltd
F:KOS1
|
US |
|
S
|
Shakarganj Ltd
KAR:SML
|
PK |
|
High Templar Tech Ltd
NYSE:HTT
|
CN |
|
Planet Properindo Jaya Tbk PT
IDX:PLAN
|
ID |
|
P
|
Pasquarelli Auto SpA
MIL:PSQ
|
IT |
|
R
|
Rohartindo Nusantara Luas Tbk Pt
IDX:TOOL
|
ID |
|
Jollibee Foods Corp
OTC:JBFCF
|
PH |
|
B
|
Bloomberry Resorts Corp
XPHS:BLOOM
|
PH |
|
E
|
EMNI Co Ltd
KOSDAQ:083470
|
KR |
|
F
|
FRtek Co Ltd
KOSDAQ:073540
|
KR |
|
M
|
Meribank Biotech Co Ltd
TPEX:4724
|
TW |
|
B
|
Blessed Textiles Ltd
KAR:BTL
|
PK |
|
Circle8 Group Inc
NASDAQ:CIRC
|
US |
|
RBB Bancorp
F:5SZ
|
US |
|
I
|
Integrated Service Technology Inc
TPEX:3289
|
TW |
|
Capital Ltd
OTC:CAPFF
|
UK |
|
Celtic PLC
F:CCP
|
UK |
|
First Resources Ltd
SGX:EB5
|
SG |
Dividends
Dividend Yield
Cosmo Pharmaceuticals NV
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Cosmo Pharmaceuticals NV
0RGI have decreased by 0%.
Payout Ratio
Cosmo Pharmaceuticals NV
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 0RGI is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
0RGI Price
Cosmo Pharmaceuticals NV
| Average Annual Return | 3.26% |
| Standard Deviation of Annual Returns | 43.73% |
| Max Drawdown | -79% |
| Market Capitalization | 841.9m CHF |
| Shares Outstanding | 15 002 100 |
| Percentage of Shares Shorted |
N/A
|
